Lactose (India) Ltd

Lactose (India) Limited informed the BSE that its board approved the reappointment of M/s. AMS & Co. Chartered Accountants as internal auditors for the financial year 2026-2027, and appointed Alpesh A. Lakeshri as cost auditor for the same period, both effective August 25, 2026. The board also approved the director’s report for the financial year 2025-2026, remuneration for Managing Director Mr. Atul Maheshwari and Whole Time Director Mrs. Sangita Maheshwari, and appointed Bigshare Services Private Limited for e-voting facility for the upcoming Annual General Meeting.

Lactose (India) Limited informed the BSE Limited on Tuesday, August 25, 2026, that its board of directors approved the reappointment of M/S. AMS & CO LLP Chartered Accountants as internal auditors for the financial year 2026-2027, and the appointment of Alpesh A. Lakeshri as cost auditor for the same period.

Lactose (India) Limited informed the BSE on August 25, 2026, that its board approved the reappointment of M/s. AMS & Co. Chartered Accountants as internal auditors for the financial year 2026-2027, and appointed Alpesh A. Lakeshri as cost auditor for the same period, succeeding M/s. Kirit Mehta & Co. The board also approved the company’s director’s report for the financial year 2025-2026, remuneration for Managing Director Mr. Atul Maheshwari and Whole Time Director Mrs. Sangita Maheshwari, and related party transactions.

Lactose (India) Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, along with a limited review report from its statutory auditor, according to a regulatory filing with the BSE Limited. The trading window for the company's securities has been closed for directors, officers, and designated employees since July 1, 2026, and will reopen 48 hours after the financial results are declared.

Lactose (India) will hold a meeting of the Board of Directors of the Company on 18 June 2026.

Net profit of Lactose (India) rose 193.75% to Rs 1.88 crore in the quarter ended March 2026 as against Rs 0.64 crore during the previous quarter ended March 2025. Sales rose 64.82% to Rs 45.77 crore in the quarter ended March 2026 as against Rs 27.77 crore during the previous quarter ended March 2025. For the full year,net profit rose 17.44% to Rs 6.06 crore in the year ended March 2026 as against Rs 5.16 crore during the previous year ended March 2025. Sales rose 40.28% to Rs 163.29 crore in the year ended March 2026 as against Rs 116.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales45.7727.77 65 163.29116.40 40 OPM %10.9712.24 -11.2614.57 - PBDT3.811.93 97 14.3612.31 17 PBT2.310.54 328 8.626.92 25 NP1.880.64 194 6.065.16 17 Powered by Capital Market - Live

Revenue from operations soared 64.81% year-on-year to Rs 45.77 crore in the quarter ended 31 March 2026. Total expenses increased 58.28% year-on-year to Rs 43.67 crore during the quarter, compared with Rs 27.59 crore in the year-ago period. The cost of materials consumed stood at Rs 28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to Rs 3.53 crore. Profit before tax (PBT) stood at Rs 2.31 crore in Q4 FY26, registering a growth of 320% from Rs 0.55 crore reported in Q4 FY25. For the full financial year FY26, the company posted a 17.44% rise in consolidated net profit to Rs 6.06 crore, while revenue rose 40.28% to Rs 163.29 crore compared with FY25. Lactose (India) is a pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. Powered by Capital Market - Live

Lactose (India) will hold a meeting of the Board of Directors of the Company on 20 May 2026.

Lactose (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 March 2026.Powered by Capital Market - Live

Net profit of Lactose (India) rose 140.91% to Rs 0.53 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. Sales rose 28.03% to Rs 36.77 crore in the quarter ended December 2025 as against Rs 28.72 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales36.7728.72 28 OPM %8.3510.34 - PBDT2.311.89 22 PBT0.880.54 63 NP0.530.22 141 Powered by Capital Market - Live